Generic name |
netupitant-palonosetron |
Strength |
300 mg/0.5 mg |
Form |
capsule |
Special Authority criteria |
Approval period |
---|---|
For the prevention of acute and delayed nausea and vomiting due to highly-emetogenic cancer chemotherapy in combination with dexamethasone. |
Up to a maximum number of standard, planned treatment cycles of highly-emetogenic cancer chemotherapy (usually 6 or fewer treatment cycles), as specified in the relevant BC Cancer chemotherapy protocol. Once-per-cycle treatment of highly-emetogenic cancer chemotherapy, administered orally on day 1 only as specified in the relevant BC Cancer chemotherapy protocol. |